Reyes Reno C, Parpura Vladimir
Department of Neurobiology, Center for Glial Biology in Medicine, Atomic Force Microscopy & Nanotechnology Laboratories, Civitan International Research Center, Evelyn F McKnight Brain Institute, University of Alabama, Birmingham, AL 35294, United States.
Neurochem Int. 2009 Jul-Aug;55(1-3):2-8. doi: 10.1016/j.neuint.2008.12.018. Epub 2009 Jan 8.
Astrocytes can exocytotically release the transmitter glutamate. Increased cytosolic Ca(2+) concentration is necessary and sufficient in this process. The source of Ca(2+) for the Ca(2+)-dependent exocytotic release of glutamate from astrocytes predominately comes from endoplasmic reticulum (ER) stores with contributions from both inositol 1,4,5-trisphosphate- and ryanodine/caffeine-sensitive stores. An additional source of Ca(2+) comes from the extracellular space via store-operated Ca(2+) entry due to the depletion of ER stores. Here transient receptor potential canonical type 1 containing channels permit entry of Ca(2+) to the cytosol, which can then be transported by the store-specific Ca(2+)-ATPase to (re)fill ER. Mitochondria can modulate cytosolic Ca(2+) levels by affecting two aspects of the cytosolic Ca(2+) kinetics in astrocytes. They play a role in immediate sequestration of Ca(2+) during the cytosolic Ca(2+) increase in stimulated astrocytes as a result of Ca(2+) entry into the cytosol from ER stores and/or extracellular space. As cytosolic Ca(2+)declines due to activity of pumps, such as the smooth ER Ca(2+)-ATPase, free Ca(2+) is slowly released by mitochondria into cytosol. Taken together, the trinity of Ca(2+) sources, ER, extracellular space and mitochondria, can vary concentration of cytosolic Ca(2+) which in turn can modulate Ca(2+)-dependent vesicular glutamate release from astrocytes. An understanding of how these Ca(2+) sources contribute to glutamate release in (patho)physiology of astrocytes will provide information on astrocytic functions in health and disease and may also open opportunities for medical intervention.
星形胶质细胞能够通过胞吐作用释放神经递质谷氨酸。在此过程中,胞质内钙离子(Ca(2+))浓度的升高是必要且充分的条件。星形胶质细胞中,依赖钙离子的谷氨酸胞吐释放所需要的钙离子,主要来源于内质网(ER)钙库,其中肌醇1,4,5-三磷酸敏感型和兰尼碱/咖啡因敏感型钙库均有贡献。另外,由于内质网钙库的耗竭,细胞外空间通过钙库操纵的钙离子内流也可作为钙离子的一个来源。在此过程中,瞬时受体电位香草酸亚型1通道可使钙离子进入胞质,随后可由内质网特异性钙ATP酶转运至内质网进行(再)填充。线粒体可通过影响星形胶质细胞胞质钙离子动力学的两个方面来调节胞质钙离子水平。在受到刺激的星形胶质细胞中,当钙离子从内质网钙库和/或细胞外空间进入胞质导致胞质钙离子浓度升高时,线粒体在钙离子的快速隔离过程中发挥作用。随着钙离子因内质网钙ATP酶等泵的活动而减少,线粒体可将游离钙离子缓慢释放回胞质中。综上所述,内质网、细胞外空间和线粒体这三种钙离子来源可改变胞质钙离子浓度,进而调节星形胶质细胞中依赖钙离子的囊泡谷氨酸释放。了解这些钙离子来源如何在星形胶质细胞的(病理)生理过程中促进谷氨酸释放,将有助于了解星形胶质细胞在健康和疾病状态下的功能,也可能为医学干预提供机会。